Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Schizophrenia

  Free Subscription


Articles published in Can J Psychiatry

Retrieve available abstracts of 19 articles:
HTML format



Single Articles


    March 2022
  1. TARRIDE JE, Blackhouse G, Abdel-Baki A, Latimer E, et al
    Economic Evaluation of Early Psychosis Interventions From A Canadian Perspective.
    Can J Psychiatry. 2022 Mar 21:7067437221087044. doi: 10.1177/07067437221087044.
    PubMed     Abstract available


  2. STEWART AJ, Patten SB, Fiest KM, Williamson TS, et al
    10-Year Trends in Healthcare Spending among Patients with Schizophrenia in Alberta, Canada.
    Can J Psychiatry. 2022 Mar 4:7067437221082885. doi: 10.1177/07067437221082885.
    PubMed     Abstract available


    February 2022
  3. ROTENBERG M, Tuck A, Anderson KK, McKenzie K, et al
    Green Space and the Incidence of Schizophrenia in Toronto, Canada.
    Can J Psychiatry. 2022 Feb 4:7067437221076722. doi: 10.1177/07067437221076722.
    PubMed    


    January 2022
  4. CALLAGHAN RC, Sanches M, Murray RM, Konefal S, et al
    Associations Between Canada's Cannabis Legalization and Emergency Department Presentations for Transient Cannabis-Induced Psychosis and Schizophrenia Conditions: Ontario and Alberta, 2015-2019.
    Can J Psychiatry. 2022 Jan 12:7067437211070650. doi: 10.1177/07067437211070650.
    PubMed     Abstract available


  5. BERTULIES-ESPOSITO B, Iyer S, Abdel-Baki A
    The Impact of Policy Changes, Dedicated Funding and Implementation Support on Early Intervention Programs for Psychosis.
    Can J Psychiatry. 2022 Jan 11:7067437211065726. doi: 10.1177/07067437211065726.
    PubMed     Abstract available


    December 2021
  6. AHLUWALIA A, Rafizadeh R, White RF, Bahji A, et al
    Listening to the Patient's Voice: A Patient-Centred Approach to Treatment-Resistant Schizophrenia.
    Can J Psychiatry. 2021 Dec 10:7067437211066262. doi: 10.1177/07067437211066262.
    PubMed    


  7. FERNANDEZ A, Pasquet-Levy M, Laure G, Thummler S, et al
    [Neurodevelopmental Disorders, Psychiatric Comorbidities and Associated Pathologies in Patients with Childhood-Onset Schizophrenia and Premorbid Autistic Symptoms.]
    Can J Psychiatry. 2021;66:1042-1050.
    PubMed     Abstract available


    September 2021
  8. LESAGE A, Courteau J, Brodeur S, Stip E, et al
    Urbanicity, Schizophrenia and Equitable Specialist Services Allocation.
    Can J Psychiatry. 2021 Sep 6:7067437211040606. doi: 10.1177/07067437211040606.
    PubMed    


    August 2021
  9. VANDEVELDE A, Metivier L, Dollfus S
    Impact cerebral structurel et fonctionnel de la Clozapine chez les patients souffrant de schizophrenie : revue systematique des etudes longitudinales en neuroimagerie.
    Can J Psychiatry. 2021;66:683-700.
    PubMed     Abstract available


    April 2021
  10. LECOMTE T, Addington J, Bowie C, Lepage M, et al
    The Canadian Network for Research in Schizophrenia and Psychoses: A Nationally Focused Approach to Psychosis and Schizophrenia Research.
    Can J Psychiatry. 2021 Apr 19:7067437211009122. doi: 10.1177/07067437211009122.
    PubMed    


    February 2021
  11. MALLA A, Dama M, Iyer S, Joober R, et al
    Understanding Components of Duration of Untreated Psychosis and Relevance for Early Intervention Services in the Canadian Context: Comprendre les Composantes de la Duree de la Psychose Non Traitee et la Pertinence de Services D'intervention Precoce Da
    Can J Psychiatry. 2021 Feb 12:706743721992679. doi: 10.1177/0706743721992679.
    PubMed     Abstract available


    December 2020
  12. TURNER A, Baker A, Dean OM, Walker AJ, et al
    Adjunctive Garcinia mangostana Linn. (Mangosteen) Pericarp for Schizophrenia: A 24-Week Double-blind, Randomized, Placebo Controlled Efficacy Trial: Pericarpe d'appoint Garcinia mangostana Linn (mangoustan) pour la schizophrenie : un essai d'efficacit
    Can J Psychiatry. 2020 Dec 23:706743720982437. doi: 10.1177/0706743720982437.
    PubMed     Abstract available


    October 2020
  13. RAFFARD S, Lebrun C, Laraki Y, Capdevielle D, et al
    Validation of the French Version of the MacArthur Competence Assessment Tool for Treatment (MacCAT-T) in a French Sample of Individuals with Schizophrenia: Validation de la version francaise de l'instrument d'evaluation des competences MacArthur-trait
    Can J Psychiatry. 2020 Oct 16:706743720966443. doi: 10.1177/0706743720966443.
    PubMed     Abstract available


    September 2020
  14. IYER SN, Mustafa SS, Moro L, Jarvis GE, et al
    Suicidality Over the First 5 Years of Psychosis: Does Extending Early Intervention Have Benefits? Suicidabilite dans les cinq premieres annees d'une psychose: Prolonger une intervention precoce a-t-il des avantages?
    Can J Psychiatry. 2020 Sep 28:706743720961714. doi: 10.1177/0706743720961714.
    PubMed     Abstract available


  15. LUO Y, Pang L, Guo C, Zhang L, et al
    Association of Urbanicity with Schizophrenia and Related Mortality in China: Association de l'urbanicite avec la schizophrenie et la mortalite qui y est reliee en Chine.
    Can J Psychiatry. 2020 Sep 3:706743720954059. doi: 10.1177/0706743720954059.
    PubMed     Abstract available


    August 2020
  16. MAHENTHARAN M, Kouyoumdjian FG, de Oliveira C, Iwajomo T, et al
    Prevalence and Predictors of Reincarceration after Correctional Center Release: A Population-based Comparison of Individuals with and without Schizophrenia in Ontario, Canada: Prevalence et predicteurs de la reincarceration apres la liberation d'un ce
    Can J Psychiatry. 2020 Aug 28:706743720953018. doi: 10.1177/0706743720953018.
    PubMed     Abstract available


  17. CHEN PH, Tsai SY, Pan CH, Chang HM, et al
    Age Effect on Incidence, Physical, and Psychiatric Comorbidity for Sudden Cardiac Death in Schizophrenia: Effet de l'age sur l'incidence, la comorbidite physique et psychiatrique de la mort cardiaque subite dans la schizophrenie.
    Can J Psychiatry. 2020 Aug 17:706743720948429. doi: 10.1177/0706743720948429.
    PubMed     Abstract available


  18. HWANG P, Hechtman L, Carboni-Jimenez A, Demchenko I, et al
    In Response to "Clinical Characteristics Associated with Early Phase Psychosis and Comorbid Substance Use": Methodological Concerns.
    Can J Psychiatry. 2020 Aug 7:706743720947636. doi: 10.1177/0706743720947636.
    PubMed    


    April 2020
  19. LIDDLE PF

    Can J Psychiatry. 2020;65:235-236.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: